'Global epo drugs market' diaporamas de présentation

Global Erythropoietin Drugs Market (Products, Applications a

Erythropoietin is a glycoprotein hormone synthesized in the bone marrow that controls and regulates the mechanism of erythropoiesis (production of red blood cells). These erythropoietin (EPO) drugs are used for treatment of chemotherapy-induced anemia; anemia is a common side-effect occurring due to chemotherapy of End Stage Renal Diseases (ESRD), cancer and HIV.

303 views • 11 slides

Aarkstore - Global Erythropoietin Drugs Market

265 views • 11 slides

Erythropoietin Drugs Market - The Industry Set to grow positively

Erythropoietin Drugs Market is Expected to Reach $11.9 Billion by 2020. Visit at: https://www.alliedmarketresearch.com/erythropoietin-market A new report by Allied Market Research titled, "Global Erythropoietin (EPO) Drugs Market (Type, Application and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013-2020", forecasts the Global EPO market to reach $11.9 billion by 2020, with promising CAGR of 9.7% from 2014 to 2020. Darbepoetin alfa is fastest growing drug class at a CAGR of 12.9% during the forecast period, owing to its high potency and minimal side-effects.

361 views • 11 slides

Global Erythropoietin Drugs Market - Size, Share, Trends

289 views • 7 slides

Complete report available at http://www.marketreportsonline.com/508284.html.

105 views • 4 slides